Evidence map›Paper›PMID 30665876›Full record

ArticleJournal of geriatric oncology2019

Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - Toward an early diagnosis of CIPN.

Mohsen Zahiri, Kevin M Chen, He Zhou, Hung Nguyen, Biruh T Workeneh, Sarvari V Yellapragada, Yvonne H Sada, Michael Schwenk, Bijan Najafi

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of geriatric oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02773329 (Managing Chemotherapy Induced Neuropathy in Cancer Patients Using Game-based Exercise), which is not on this map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02773329 phase2completednot on this map

Managing Chemotherapy Induced Neuropathy in Cancer Patients Using Game-based Exercise

TypeinterventionalSponsorBaylor College of MedicineRan2016 to 2019Enrolled35ConditionsChemotherapy Induced Peripheral Neuropathy, CancerArmssensor-based interactive exercise (game-based exercise), Intervention without game-based exercise
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Observational
  8. Gait as a quantitative indicator of the severity of chemotherapy-induced peripheral neuropathy: a pilot study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  9. Observational
  10. Incidence and associated factors of falls in patients with chemotherapy-induced peripheral neuropathy: a scoping review and evidence mapping.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Mohsen ZahiriInterdisciplinary Consortium on Advanced Motion Performance (iCAMP), Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
Kevin M ChenInterdisciplinary Consortium on Advanced Motion Performance (iCAMP), Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
He ZhouInterdisciplinary Consortium on Advanced Motion Performance (iCAMP), Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
Hung NguyenInterdisciplinary Consortium on Advanced Motion Performance (iCAMP), Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
Biruh T WorkenehDepartment of Nephrology, Division of Internal Medicine, MD Anderson, Houston, TX, USA.
Sarvari V YellapragadaDepartment of Medicine, Section of Hematology and Oncology, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA; Department of Hematology and Oncology, Michael E. DeBakey VA Medical Center, Houston, TX, USA.
Yvonne H SadaDepartment of Medicine, Section of Hematology and Oncology, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA; Department of Hematology and Oncology, Michael E. DeBakey VA Medical Center, Houston, TX, USA.
Michael SchwenkNetwork Aging Research (NAR), Heidelberg University, Heidelberg, Germany; Department of Sports and Sports Sciences, Heidelberg University, Heidelberg, Germany.
Bijan NajafiInterdisciplinary Consortium on Advanced Motion Performance (iCAMP), Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA. Electronic address: bijan.najafi@bcm.edu.
Baylor College of Medicine · USMichael E. DeBakey VA Medical Center · USHeidelberg University · DEThe University of Texas MD Anderson Cancer Center · US

Funding

Managing chemotherapy induced neuropathy in Cancer patients using ExerGamingR21CA190933 · NCI · BAYLOR COLLEGE OF MEDICINE · PI GARLAND, LINDA LEE, NAJAFI, BIJAN · 2016 to 2017
$459k
NCI NIH HHS R21 CA190933
6 · The paper itself

Abstract

objectiveAn essential component for optimizing quality of life in adults with cancer is determining the degree to which therapy may negatively impact motor-performance, so that patients can maintain their quality of life and independence. This study examined whether instrumented gait and balance could determine the magnitude of deterioration in motor-performance from chemotherapy-induced peripheral neuropathy (CIPN).

methodsWe recruited 84 adults with cancer (age = 71.1 ± 9.7 years old, BMI = 26.8 ± 6.2 kg/m

resultsAll gait and balance parameters were deteriorated in the group with cancer compared to non-cancer group with the largest effects observed for stride-time (11%, Cohen's effect size d = 1.00, p < 0.001) and eyes-closed ankle sway (94%, d = 0.49, p = 0.001). The same trend was observed when the Severe-CIPN subgroup was compared to the Mild-CIPN. VPT correlates significantly with motor deterioration, with the largest correlation found in stride-time (Rho = 0.37, p = 0.007). Severe-CIPN subjects were significantly older and overall had more deterioration in the majority of motor-performance parameters after adjusting for age (p < 0.050).

conclusionThese results confirmed the negative impact of CIPN on motor-performance with the largest effects on ankle stability and stride-time. VPT is a predictor of motor deterioration and may be used to determine the severity of CIPN symptom.

Indexed as

Wearable Electronic DevicesAgedAged, 80 and overAntineoplastic AgentsCase-Control StudiesFemaleGaitHumansMaleMotor ActivityNeoplasmsPeripheral Nervous System DiseasesPostural BalanceSeverity of Illness IndexAntineoplastic AgentsAdults with cancerBalanceChemotherapy-Induced Peripheral NeuropathyFallsGaitMotor performanceNeuropathyPlantar numbnessWearables

Identifiers

PMID30665876
PMCPMC6639160
OpenAlexW2908793808

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.